Home >> Hematology, Volume 14, Number 4

Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line

Authors: Onoda, Masahiro1; Nakaseko, Chiaki2; Yokota, Akira1; Saito, Yasushi2

Source: Hematology, Volume 14, Number 4, August 2009 , pp. 213-219(7)

Publisher: Maney Publishing

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Adhesive interactions between hematopoietic progenitor cells and extracellular matrix can improve progenitor cell survival. These mechanisms involve a number of different molecules. CD44 is one such molecule, although its molecular basis has not been elucidated. In this study, we investigated the effect of CD44 monoclonal antibodies and hyaluronan, which is a ligand of CD44, on drug-induced apoptosis in human myeloid cell line KG1. Preincubation with anti-CD44 monoclonal antibody J173 or a lower-molecular-weight form of hyaluronan (LMW-HA) could reduce drug-induced apoptosis in a dose-dependent manner from 23·0 ± 1·4% to 5·9 ± 5·0% (p<0·01) or 9·7 ± 1·8% (p<0·01) respectively. On the other hand, another anti-CD44 monoclonal antibody L178 and the native high-molecular-weight polymer of hyaluronan had no effect on drug-induced apoptosis. Furthermore, J173 and LMW-HA induced a rapid increase in tyrosine phosphorylation of intracellular proteins. Genistein, a protein tyrosine kinase inhibitor, abrogated the inhibition of drug-induced apoptosis promoted by J173 and LMW-HA. These results suggest that the anti-apoptotic effect by ligation of CD44 was mediated by tyrosine phosphorylation of intracellular proteins. These data indicate that tyrosine phosphorylation via CD44 is involved in the survival of primitive myeloid cells.

Keywords: HEMATOPOIETIC PROGENITOR CELLS; CD44; APOPTOSIS; HYALURONAN

Document Type: Research Article

DOI: http://dx.doi.org/10.1179/102453309X426236

Affiliations: 1: Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan 2: Department of Clinical Cell Biology, Chiba University Graduate School of Medicine, Chiba, Japan

Publication date: 2009-08-01

Related content
Marked list

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page